SCHEMBL18179213

SCHEMBL18179213

COC(=O)c1cc(C(=O)CBr)c(F)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ PDGFRA P16234 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ FGFR3 P22607 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ GSK3B P49841 2/20 0.37
▸ PTPN1 P18031 1/20 0.36
▸ MAPT P10636 5/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ GAA P10253 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HPGDS O60760 1/20 0.35
▸ SOS1 Q07889 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31386217 0.88 GSK3B (0.37) PDGFRBFGFR1PDGFRAFLT1FGFR3
SCHEMBL31386371 0.85 PDGFRB (0.43) PDGFRBFGFR1PDGFRAFLT1FGFR3
SCHEMBL15751856 0.80 GSK3B (0.38) GSK3BPTPN1MAPTALDH1A1HPGDS
SCHEMBL27890 0.79 KDM4E (0.43) PDGFRBFGFR1PDGFRAFLT1FGFR3
SCHEMBL25190853 0.78 GSK3B (0.47) GSK3BPTPN1MAPTALDH1A1GAA
SCHEMBL7920331 0.78 KDM4E (0.49) GSK3BPTPN1MAPTALDH1A1GAA
SCHEMBL15544203 0.78 ALDH1A1 (0.46) GSK3BPTPN1MAPTALDH1A1GAA
SCHEMBL1418414 0.78 PDGFRB (0.42) PDGFRBFGFR1PDGFRAFLT1FGFR3
SCHEMBL20470613 0.78 PDGFRB (0.42) PDGFRBFGFR1PDGFRAFLT1FGFR3
SCHEMBL20571340 0.77 SOS1 (0.48) PDGFRBFGFR1PDGFRAFLT1FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160311803-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS 3-V BIOSCIENCES, INC. 2016-10-27 — — US disclosed
US-20160311803-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS 3-V BIOSCIENCES, INC. 2016-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311803-A1 HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS FASN, FADS1, FADS2 PDGFRB 3485/4885FGFR1 1192/4885PDGFRA 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback